The tweet was deleted by the author.
But we saved everything 🙂.
Simulations Plus draws attention to the vital role of interpretability in model evaluation for the pharmaceutical and life sciences sectors.
Sandra Suarez-Sharp, a leading authority on model validation, examines how interpretability supports regulatory confidence. Her insights explore methods for evaluating covariates, establishing biological plausibility, and extrapolating findings to new populations and dosing regimens—core issues in drug development. The company emphasizes that clarity in model outputs is increasingly seen as critical by both industry stakeholders and regulators.
Simulations Plus has previously cautioned that regulatory decisions depend on credible, transparent modeling. The company also launched QSP Flex to enable the integration of validated QSP models into major analytics platforms. Recent initiatives reflect Simulations Plus’s continued focus on verifiable model outputs in drug development.